July 20 (Reuters) - Australia's competition watchdog on Thursday raised concerns over Australian Clinical Labs' (ACL) A$1.52 billion ($1.03 billion) buyout offer for medical centre operator Healius (HLS) , who had rejected the proposal in May.
The Australian Competition and Consumer Commission said the acquisition would lessen competition in the Australian pathology services markets.
($1 = 1.4775 Australian dollars)
News: HLS Regulator flags concerns on Australian Clinical's buyout offer for Healius
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
0.010(0.58%) |
Mkt cap ! $1.248B | |||
| Open | High | Low | Value | Volume |
| $1.71 | $1.73 | $1.69 | $1.642M | 958.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2230 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| HLS (ASX) Chart |